Victory Capital Management Inc. Has $436.27 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Victory Capital Management Inc. lessened its position in UnitedHealth Group Incorporated (NYSE:UNH) by 3.5% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 828,664 shares of the healthcare conglomerate’s stock after selling 29,749 shares during the period. Victory Capital Management Inc. owned approximately 0.09% of UnitedHealth Group worth $436,267,000 as of its most recent filing with the SEC.

A number of other large investors also recently modified their holdings of the stock. Richelieu Gestion SA bought a new stake in UnitedHealth Group during the fourth quarter worth $26,000. Robbins Farley bought a new stake in UnitedHealth Group during the third quarter worth $25,000. CGC Financial Services LLC lifted its holdings in UnitedHealth Group by 1,000.0% during the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after acquiring an additional 50 shares during the period. NewSquare Capital LLC raised its stake in shares of UnitedHealth Group by 340.0% in the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock valued at $33,000 after buying an additional 51 shares during the period. Finally, LFA Lugano Financial Advisors SA raised its stake in shares of UnitedHealth Group by 148.1% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock valued at $35,000 after buying an additional 40 shares during the period. Institutional investors own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the company. Barclays lifted their price target on UnitedHealth Group from $534.00 to $560.00 and gave the company an “overweight” rating in a research report on Wednesday, April 17th. Truist Financial reiterated a “buy” rating and issued a $600.00 price objective on shares of UnitedHealth Group in a report on Wednesday, April 17th. Morgan Stanley lowered their price target on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a research report on Friday, April 5th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $591.00 price target on shares of UnitedHealth Group in a research report on Wednesday, April 10th. Finally, Wells Fargo & Company lowered their price target on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a research report on Monday, April 8th. Four investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and an average price target of $570.05.

Insider Buying and Selling at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In other news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

UnitedHealth Group Stock Up 0.9 %

UNH traded up $4.49 during trading on Wednesday, hitting $488.19. 1,134,251 shares of the company’s stock traded hands, compared to its average volume of 4,425,398. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $554.70. The company’s 50 day simple moving average is $484.44 and its two-hundred day simple moving average is $513.42. The stock has a market capitalization of $449.17 billion, a price-to-earnings ratio of 29.74, a PEG ratio of 1.42 and a beta of 0.54. The company has a current ratio of 0.85, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company had revenue of $99.80 billion for the quarter, compared to analysts’ expectations of $99.23 billion. During the same period last year, the firm earned $6.26 EPS. UnitedHealth Group’s revenue for the quarter was up 8.6% compared to the same quarter last year. Analysts predict that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were issued a dividend of $1.88 per share. The ex-dividend date was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a yield of 1.54%. UnitedHealth Group’s dividend payout ratio is presently 45.97%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.